Summary of the study and findings
A clinical study was conducted by the Sahlgrenska Academy at University of Gothenburg, Sweden to find out whether the use of probiotics can alter the composition of intestinal bacteria in humans with colon cancer. Previous studies have demonstrated beneficial effects of probiotic bacteria in reducing mucosal inflammation and colon tumour development in animals, but supporting clinica data in humans were limited. The Swedish study involved 15 patients with colon cancer at Sahlgrenska University Hospital. Eight of them were given two tablets a day of ProBion Clinica, the brand chosen as the beneficial probiotics for the study. The other 7 colon cancer patients, together with another 21 non-cancer patients served as the control group and were given no probiotic intervention.